Timmerman Report
The Long Run with Luke Timmerman
"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes 28.05.2025 1:03:25
Marea Therapeutics CEO Josh Lehrer and CSO Ethan Weiss on a new angle of attack against cardiovascular disease and diabetes.
Ep178: Peyton Greenside on ML-Guided Biologics Discovery 13.05.2025 1:02:56
Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.
Ep177: Kevin Parker on Finding Cancer Drug Targets 14.04.2025 58:13
Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.
Ep176: David Roblin on Building a TechBio Company 31.03.2025 1:19:28
David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies 16.03.2025 1:10:46
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
Ep174: Najat Khan on the TechBio Movement 03.03.2025 1:07:16
Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders 11.02.2025 57:56
Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale 27.01.2025 1:20:53
Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.
Ep171: Ram Aiyar on RNA Editing Medicines 13.01.2025 1:01:48
Ram Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines.
Ep170: David Schenkein on Investing in the Future of Biotech 02.01.2025 59:52
David Schenkein, general partner at GV, on investing in the future of biotech.
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines 11.12.2024 1:02:28
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer 25.11.2024 1:00:23
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.
Ep167: Leslie Williams on transfer RNA therapies 06.11.2024 1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity 15.10.2024 1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.
Ep165: Zach Hornby on Tackling Cancer Drug Resistance 26.09.2024 1:02:45
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients 05.09.2024 56:39
Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases 14.08.2024 1:08:19
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.
Ep162: Sean McClain on AI for Biologic Drug Discovery 16.07.2024 1:05:59
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.
Ep161: Jeff Stein on a Long-Lasting Flu Drug 01.07.2024 1:08:51
Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.
Ep160: Abe Ceesay on Precision Neuroscience 17.06.2024 1:08:48
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease 03.06.2024 1:07:22
Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery 20.05.2024 1:00:44
David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery 01.05.2024 56:33
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.
Ep156: David Liu on New Tools and Techniques for Biology 16.04.2024 1:52:57
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's 06.03.2024 1:02:37
Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.
Similar podcasts
Listen to the The Long Run with Luke Timmerman podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
